Gerber A - Search Results

1

[Methods of health economic evaluation for health services research].

Icks A, Chernyak N, Bestehorn K, Brüggenjürgen B, Bruns J, Damm O, Dintsios CM, Dreinhöfer K, Gandjour A, Gerber A, Greiner W, Hermanek P, Hessel F, Heymann R, Huppertz E, Jacke C, Kächele H, Kilian R, Klingenberger D, Kolominsky-Rabas P, Krämer H, Krauth C, Lüngen M, Neumann T, Porzsolt F, Prenzler A, Pueschner F, Riedel R, Rüther A, Salize HJ, Scharnetzky E, Schwerd W, Selbmann HK, Siebert H, Stengel D, Stock S, Völler H, Wasem J, Schrappe M. Icks A, et al. Among authors: gerber a. Gesundheitswesen. 2010 Dec;72(12):917-33. doi: 10.1055/s-0030-1262859. Epub 2010 Sep 23. Gesundheitswesen. 2010. PMID: 20865653 German.

2

The nocebo effect: a reason for patients' non-adherence to generic substitution?

Weissenfeld J, Stock S, Lüngen M, Gerber A. Weissenfeld J, et al. Among authors: gerber a. Pharmazie. 2010 Jul;65(7):451-6. Pharmazie. 2010. PMID: 20662309 Review.

3

Comment on "Where's the value in health care"?

Lungen M, Gerber A. Lungen M, et al. Among authors: gerber a. Value Health. 2007 Mar-Apr;10(2):170; author reply 171. doi: 10.1111/j.1524-4733.2006.00164.x. Value Health. 2007. PMID: 17391426 Free article. No abstract available.

4

[IQWiG's methods for the cost-benefit assessment : Comparison with an international reference scenario].

Schwalm A, Danner M, Seidl A, Volz F, Dintsios CM, Gerber A. Schwalm A, et al. Among authors: gerber a. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Jun;53(6):615-22. doi: 10.1007/s00103-010-1067-2. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010. PMID: 20449550 German.

5

[Efficiency of computer-based documentation in long-term care--preliminary project].

Lüngen M, Gerber A, Rupprecht C, Lauterbach KW. Lüngen M, et al. Among authors: gerber a. Pflege Z. 2008 Jun;61(6):334-9. Pflege Z. 2008. PMID: 18605616 German.

6

Substitution of theophylline slow-release formulations according to the rebate contracts in the German statutory health insurance.

Weissenfeld J, Lüngen M, Stock S, Drabik A, Gerber A. Weissenfeld J, et al. Among authors: gerber a. Arzneimittelforschung. 2009;59(9):476-81. doi: 10.1055/s-0031-1296428. Arzneimittelforschung. 2009. PMID: 19856796

7

Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany.

Mertens J, Stock S, Lüngen M, von Berg A, Krämer U, Filipiak-Pittroff B, Heinrich J, Koletzko S, Grübl A, Wichmann HE, Bauer CP, Reinhardt D, Berdel D, Gerber A. Mertens J, et al. Among authors: gerber a. Pediatr Allergy Immunol. 2012 Sep;23(6):597-604. doi: 10.1111/j.1399-3038.2012.01304.x. Epub 2012 May 25. Pediatr Allergy Immunol. 2012. PMID: 22624978 Clinical Trial.

8

What can we learn from German health incentive schemes?

Schmidt H, Gerber A, Stock S. Schmidt H, et al. Among authors: gerber a. BMJ. 2009 Sep 24;339:b3504. doi: 10.1136/bmj.b3504. BMJ. 2009. PMID: 19778973 No abstract available.

9

[Does the lack of evidence of effectiveness among international studies on interventions in prevention and health promotion have an impact on a German Act of Prevention?].

Lüngen M, Schröer-Günther MA, Passon AM, Gerber A, Lauterbach KW. Lüngen M, et al. Among authors: gerber a. Med Klin (Munich). 2009 Feb 15;104(2):101-7. doi: 10.1007/s00063-009-1021-y. Epub 2009 Feb 26. Med Klin (Munich). 2009. PMID: 19242660 Review. German.

10

Evidence-based medicine is rooted in Protestant exegesis.

Gerber A, Lungen M, Lauterbach KW. Gerber A, et al. Med Hypotheses. 2005;64(5):1034-8. doi: 10.1016/j.mehy.2004.12.015. Med Hypotheses. 2005. PMID: 15780507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,001 results

Search Page